******************SMART INVESTORS

New Post Public Reply Private Reply Replies (0) Message Board
WARMBUFFETT

******************SMART INVESTORS ONLY***************************

 

DEAR INVESTOR,  HAD A CONF.CALL WITH 2 DOZ. OTHER LONGS AND COMPANY SUNDAY.  DUE TO THE FACT IT WAS PRed LAST MONTH ABOUT CDFT-QB BECOMING A B.D.C.  IT HAS GONE OVER MOST SHs HEADS,  I WAS TOLD THAT CDFT HAS A BDC COMPANY THAT   IT WILL MERGE WITH,  IT WILL RESTRUCTURE IT CHANGE TICKERS AND MERGE MARKET CAPS.  CDFT SHs WILL BE CONVERTED TO PREFERRED SHARES. THEY ALWAYS KNEW DO TO MANIPULATION AND CAP THAT IT WOULD NEVER GET TO THE 2.00 AMEX MIN WITHOUT A MERGER. THEY ALSO SHOW 200K A MONTH IN BUYS WICH THEY KNOW IS  MANIPULATION,  SINCE THIS NEWS THE BASHERS HAVE GONE ON  OVERTIME ON THE BOARD,  THEY KNOW THEY WILL HAVE TO COVER,  I THINK THIS COMPANY WANTS THIS BAD AND I BELIEVE THEM, THEY HAVE BEEN STRAIGHT ABOUT EVERYTHING. I FOUND OUT MOST PEOPLE DON'T KNOW WHAT A B.D.C. IS. WE HAVE THE BEST DD HOUNDS ON OUR BOARD. I WELCOME YOU TO CHECK IT OUT AS AN OPERTUNITY LIKE THIS COMES ALONG ABOUT EVERY 5 YEARS. LOOK AT THE STOCK {LODE} SAME PEOPLE TOOK IT FROM PENNYS TO DOLLARS.

 

Citadel EFT, Inc. (OTCQB: CDFT) CEO Gary DeRoos is pleased to announce that he will be retiring 117,000,000 of his 168,000,000 common securities effective May 13th, 2013. This is two days prior to when Citadel EFT is due to post its second quarter results

 

Zero Debt
Over 3,000,000 in Net Equity
Revenue Generation Business, $450k per annum
$250,000 in dividends paid to Gary DeRoos, Series A
Continued growth in sales of credit card processing business
The company has CASH, no going concern
It's adding more value on the balance sheet from Q to Q
It's retired it's Professional Contracts,
Management has removed all of its compensation securities
Management now intends to lower its Issued Capital
The Market Cap of the Company is way under value
Management has met with AMEX people, PRE approved
Company float has remained at 65,000,000, no new issuances
The Company does not pay or sanction paid for promo
The Company is a OTCQB, not a pink sheet company
The Company is an a SEC filer, it's information is audited
The Company hires independent evaluators to buy assets
The Company is building a board with pedigree
The Company has been honest, every time it retired stock
The Company has made itself available to answer inquiries
The Company has done conference calls using a shareholder
The stock has come from .0011 to a high of .027 cents
The stock has traded in the penny range for the last month
The stock has been oversold, more than the size of the float
The longs are not budging from their positions

He further states, "We are extremely pleased with the improvements we are making to our balance sheet. We expect, in the next two quarters, to improve our cash position and our overall net stock holders equity. We have retired all compensation securities to management, and lowering the Issued Capital was always part of our agenda. The significance of choosing May 13th as the effective date is that it is before our second quarter results are due to be posted. And we have indicated in a previous press release that we would lower the issued capital before Q2 was posted. We are meeting that obligation, and look forward to any shareholder inquiries on the matter."  GARY 714-423-0701

Follow me to the TRII board, 20 bagger by XMAS
BRAND NEW MILL READY TO CHEW!
Cash-Flow Positive in less than Two Q's

53225022_trio-logo-header-small.jpg
1945865170_xxl[oTRIO_Logo_.jpg

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 75

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 102

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 80

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 112

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 22

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
InPHRED's Award Brings 1310 nm VCSELs Into Focus at IEEE

Updated Category News Views 64

A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...

Continue Reading
Hanon's BMW Thermal Win Matters Beyond the Trophy Case Today

Updated Category News Views 11

A 16-Kilogram Box Just Grabbed the Auto Supply Chain’s Attention Hanon Systems did not win these two 2026 PACE honors by polishing up some old hose-and-valve package. Its Highly Integrated Cooling Entity, or HICE, is aimed right at a stubborn electric-vehicle problem: keeping a vehicle’s thermal systems controlled without turning the architecture into a sprawling,...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 71

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading

Top 5 Most Recently Viewed Articles

TriPost Partners with Brixton Capital for Retail Expansion

Updated Category News Views 254

Strategic Partnership between TriPost and Brixton Capital TriPost Capital Partners, a real estate private equity firm, is thrilled to announce a significant partnership with Brixton Capital for acquiring a grocery-anchored retail portfolio. This collaboration focuses on high-quality investment opportunities in rapidly developing markets. Details of the Portfolio...

Continue Reading
Archer Aviation: Pioneering A New Era in Defense Technology

Updated Category News Views 200

Archer Aviation: A New Vision for Military Transportation When considering groundbreaking advancements in transportation, one might think of popular electric cars, but now there's a fresh contender: Archer Aviation Inc. This company stands out in the realm of electric vertical takeoff and landing aircraft (eVTOL), showcasing a vision that aligns with modern defense needs....

Continue Reading
Understanding Civil Claims for Rideshare Sexual Assault Victims

Updated Category News Views 279

Understanding Civil Claims for Rideshare Sexual Assault Victims Victims of sexual assault during rideshare trips have avenues to seek justice and compensation. With cases involving rideshare companies like Uber and Lyft, survivors might find themselves facing challenging circumstances after an assault. Fortunately, there are legal options available for those affected by...

Continue Reading
Ramsay Santé Optimizes Debt Structure with New TLB Reppricing

Updated Category News Views 242

Ramsay Santé Successfully Reprices Term Loans for Financial Growth Ramsay Santé recently achieved a significant milestone by repricing its €1,025 million Term Loan B4 (TLB4) and extending its €425 million Term Loan B3 (TLB3), effectively consolidating them into a new Term Loan B5. This strategic move is set to enhance their financial standing as part of their...

Continue Reading
NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading